Zucara Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 12

Zucara Therapeutics General Information

Description

Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy is delivered as a subcutaneous injection, which will benefit patients by addressing the significant morbidity and mortality associated with hypoglycemia, enabling healthcare providers to change diabetes management and improve patient health.

Contact Information

Website
www.zucara.ca
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • MaRS Centre, 101 College Street
  • Suite 120-I
  • Toronto, Ontario M5G 1L7
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • MaRS Centre, 101 College Street
  • Suite 120-I
  • Toronto, Ontario M5G 1L7
  • Canada

Zucara Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zucara Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private 01-Jun-2026 Completed Clinical Trials - Phase 2
12. Later Stage VC (Series B) 28-Feb-2025 Completed Clinical Trials - Phase 2
11. Accelerator/Incubator 01-Dec-2023 Completed Clinical Trials - Phase 2
10. Grant 15-Jun-2023 Completed Clinical Trials - Phase 2
9. Grant 02-May-2022 Completed Clinical Trials - Phase 1
8. Later Stage VC (Series A) 31-Mar-2020 Completed Clinical Trials - Phase 1
7. Grant 12-Jul-2019 Completed Pre-Clinical Trials
6. Debt - General 09-Apr-2018 Completed Pre-Clinical Trials
5. Accelerator/Incubator 09-Feb-2018 $525K Completed Pre-Clinical Trials
4. Grant 08-Feb-2018 $350K $525K Completed Pre-Clinical Trials
To view Zucara Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Zucara Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy i
Drug Discovery
Toronto, Canada
12 As of 2022

Soborg, Denmark
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zucara Therapeutics Competitors (2)

One of Zucara Therapeutics’s 2 competitors is Zealand Pharma, a Formerly VC-backed company based in Soborg, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zealand Pharma Formerly VC-backed Soborg, Denmark
Xeris Biopharma Holdings Formerly VC-backed Chicago, IL
You’re viewing 2 of 2 competitors. Get the full list »

Zucara Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zucara Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sanofi Corporation Minority
T1D Fund Venture Capital Minority
University of Toronto University Minority
The UTEST Program Accelerator/Incubator
University of Toronto Entrepreneurship Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Zucara Therapeutics FAQs

  • When was Zucara Therapeutics founded?

    Zucara Therapeutics was founded in 2015.

  • Where is Zucara Therapeutics headquartered?

    Zucara Therapeutics is headquartered in Toronto, Canada.

  • What is the size of Zucara Therapeutics?

    Zucara Therapeutics has 12 total employees.

  • What industry is Zucara Therapeutics in?

    Zucara Therapeutics’s primary industry is Drug Discovery.

  • Is Zucara Therapeutics a private or public company?

    Zucara Therapeutics is a Private company.

  • What is Zucara Therapeutics’s current revenue?

    The current revenue for Zucara Therapeutics is .

  • How much funding has Zucara Therapeutics raised over time?

    Zucara Therapeutics has raised $50.4M.

  • Who are Zucara Therapeutics’s investors?

    Sanofi, T1D Fund, University of Toronto, The UTEST Program, and University of Toronto Entrepreneurship are 5 of 12 investors who have invested in Zucara Therapeutics.

  • Who are Zucara Therapeutics’s competitors?

    Zealand Pharma and Xeris Biopharma Holdings are competitors of Zucara Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process